Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 378d-1 (MIR378D1) is a short, non-coding RNA gene that regulates gene expression by binding to target mRNAs and inhibiting their translation or promoting their degradation. MIR378D1 is transcribed as part of a primary transcript (pri-miRNA) and processed by ribonucleases (Drosha and Dicer) into its mature form, which is incorporated into the RNA-induced silencing complex (RISC). miR-378d-1, as part of the broader miR-378 family, is implicated in key biological processes such as cell proliferation, apoptosis, differentiation, metabolic regulation (notably in adipose and cardiac tissues), and angiogenesis. It has been experimentally linked to various diseases including cancers and cardiovascular conditions, and its expression pattern is being evaluated as a non-invasive biomarker for cancer detection, progression, and prognosis. No direct drug therapies currently target MIR378D1, but experimental strategies for miRNA modulation are under investigation. This information is synthesized based on current genetic, biomedical, and functional data and reflects the current standard understanding of microRNA 378d-1 and its gene MIR378D1.
Not applicable (standard drugs do not directly target this microRNA; experimental strategies may use anti-miRs or miRNA mimics to upregulate or downregulate its activity.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 378d-1 (MIR378D1).